Immunotherapy Prolongs Survival in Recurrent, Persistent or Metastatic Cervical Cancer
The addition of immunotherapy to standard first-line treatment extends survival by eight months
ESMO Media Releases
Adjuvant Immunotherapy Prolongs Recurrence-Free Survival in Resected Stage II B/C Melanoma
The first randomised phase III clinical trial in stage II melanoma has shows a 35% reduction in the risk of recurrence with adjuvant pembrolizumab compared with placebo
Better Support for Long-Term Symptoms is Needed to Help Patients Live Life After Cancer
Study shows that a significant proportion of survivors continue to suffer from burdensome symptoms for several years
Patients and Non-Oncology Doctors Struggle to Keep up with the Pace of Change in Oncology, Research Shows
Two studies [to be] presented at the ESMO Congress 2021 suggest a need for broader education on current standards of cancer care
Children of Cancer Patients are Too Often Excluded from the Disease Journey, Research Shows
New research [to be] presented at the ESMO Congress 2021 suggests that adequate communication and support for children of cancer patients still represents a significant unmet need that parents require help to fulfil.
Oncology Research Rebounds from Pandemic Low, but Shows Cancer Patients Need Special Attention After COVID-19 Recovery
ESMO launches International Cancer Foundation to make the best cancer care accessible to patients worldwide
ESMO Congress 2021, 16-21 September
The ESMO Congress 2021 will be held as a virtual meeting, on 16-21 September 2021.
Bowel Cancer Data Reinforce Need to Reduce Unnecessary Antibiotic Use
Doctors and patients are being advised to reduce unnecessary antibiotic use following new data suggesting that these medicines may increase the risk of cancer of the large intestine (colon), especially in people under 50 years
Poorer Survival in Obese Colorectal Cancer Patients Possibly Linked to Lower Chemotherapy Doses
Obese patients with colorectal cancer receive lower cumulative doses of adjuvant chemotherapy, relative to their body surface area (BSA), than non-obese patients, show results from a large meta-analysis reported at the ESMO World Congress on Gastrointestinal Cancer 2021
Blood Test for Early Detection of Cancer: Final Study Results Support Screening Use
Test can detect over 50 types of cancer, often before symptoms show
ESMO World Congress on Gastrointestinal Cancer 2021, 30 June - 3 July
The 2021 World Congress on Gastrointestinal Cancer will be held as a virtual meeting.
Adding Checkpoint Inhibition to Anti-HER2 Breast Cancer Therapy Brings no Benefit
Adding an immune checkpoint inhibitor to anti-HER2 treatment in breast cancer does not improve pathological complete response (pCR), according to the primary analysis of the IMpassion050 trial presented today during the ESMO Virtual Plenary.